EDP Sciences logo
Submit your paper
Search
Menu
Home All issues Volume 27 (2020) OCL, 27 (2020) 7 References
Issue
OCL
Volume 27, 2020
Lipids and health / Lipides et santé
Article Number 7
Number of page(s) 10
Section Nutrition - Health
DOI https://doi.org/10.1051/ocl/2019046
Published online 17 February 2020
  • Alvheim AR, Torstensen BE, Lin YH, et al. 2014. Dietary linoleic acid elevates the endocannabinoids 2-AG and anandamide and promotes weight gain in mice fed a low-fat diet. Lipids 49: 59–69. [CrossRef] [PubMed] [Google Scholar]
  • Artmann A, Petersen G, Hellgren LI, et al. 2008. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta 1781: 200–212. [CrossRef] [PubMed] [Google Scholar]
  • Banni S, Di Marzo V. 2010. Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood. Mol Nutr Food Res 54: 82–92. [CrossRef] [PubMed] [Google Scholar]
  • Banni S, Carta G, Murru E, et al. 2011. Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects. Nutr Metabol 8. [Google Scholar]
  • Batetta B, Griinari M, Carta G, et al. 2009. Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J Nutr 139(8): 1495–1501. [PubMed] [Google Scholar]
  • Bouwens M, van de Rest O, Dellschaft N, et al. 2009. Fish oil supplementation induces anti-inflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 90: 415–424. [CrossRef] [PubMed] [Google Scholar]
  • Burdge G. 2004. Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutri Metab Care 7: 137–144. [CrossRef] [PubMed] [Google Scholar]
  • Cho HP, Nakamura MT, Clarke SD. 1999. Cloning, expression, and nutritional regulation of the mammalian delta-6 desaturase. J Biol Chem 274: 471–477. [CrossRef] [PubMed] [Google Scholar]
  • Cho HP, Nakamura M, Clarke SD. 1999. Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. J Biol Chem 274: 37335–37339. [PubMed] [Google Scholar]
  • Cintra DE, Ropelle ER, Moraes JC, et al. 2012. Plos One 7: e30571. [CrossRef] [PubMed] [Google Scholar]
  • Claussnitzer M, Dankel SN, Kim KH, et al. 2015. FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med 373: 895–907. [Google Scholar]
  • Clement K, Viguerie N, Poitou C, et al. 2004. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 18: 1657–1669. [CrossRef] [PubMed] [Google Scholar]
  • Couet C, Delarue J, Ritz P, Antoine JM, Lamisse F. 1997. Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes Relat Metab Disord 21: 637–643. [Google Scholar]
  • Crujeiras AB, Parra D, Milagro FI, et al. 2008. Differential expression of oxidative stress and inflammation related genes in peripheral blood mononuclear cells in response to a low-calorie diet: a nutrigenomics study. OMICS 12: 251–261. [Google Scholar]
  • Dahlman I, Linder K, Arvidsson Nordström E, et al. 2005. Changes in adipose tissue gene expression with energy-restricted diets in obese women. Am J Clin Nutr 81: 1275–1285. [CrossRef] [PubMed] [Google Scholar]
  • De Petrocellis L, Di Marzo V. 2009. An introduction to the endocannabinoid system: from the early to the latest concepts. Best Pract Res Clin Endocrinol Metab 23: 1–15. [CrossRef] [PubMed] [Google Scholar]
  • Di Marzo V, Griinari M, Carta G, et al. 2010. Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats. Int Dairy J 20(4): 231–235. [Google Scholar]
  • Di Marzo V, Stella N, Zimmer A. 2015. Endocannabinoid signalling and the deteriorating brain. Nat Rev Neurosci 16: 30–42. [CrossRef] [PubMed] [Google Scholar]
  • Du S, Jin J, Fang W, Su Q. 2015. Does fish oil have an anti-obesity effect in overweight/obese adults? A meta-analysis of randomized controlled trials. Plos One 10(11): e0142652. [CrossRef] [PubMed] [Google Scholar]
  • Dyall SC, Michael-Titus AT. 2008. Neurological benefits of omega-3 fatty acids. Neuromol Med 10: 219–235. [CrossRef] [Google Scholar]
  • Frøyland L, Madsen L, Vaagenes H, et al. 1997. Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism. J Lipid Res 38(9): 1851–1858. [PubMed] [Google Scholar]
  • Garaulet M, Hernandez-Morante JJ, Lujan J, Tebar FJ, Zamora S. 2006. Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in overweight/obese humans. Int J Obes (Lond) 30: 899–905. [CrossRef] [PubMed] [Google Scholar]
  • Hansen TV, Vik A, Serhan CN. 2019. The protectin family of specialized pro-resolving mediators: potent immunoresolvents enabling innovative approaches to target obesity and diabetes. Front Pharmacol 9: 1582. [CrossRef] [PubMed] [Google Scholar]
  • Hill AM, Buckley JD, Murphy KJ, Howe PR. 2007. Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors. Am J Clin Nutr 85: 1267–1274. [CrossRef] [PubMed] [Google Scholar]
  • Ichimura A, Hirasawa A, PoulainGodefroy O, et al. 2012. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483: 350–354. [Google Scholar]
  • Jensen CL, Prager TC, Fraley JK, Chen H, Anderson RE, Heird WC. 1997. Effect of dietary linoleic/alpha-linolenic acid ratio on growth and visual function of term infants. J Pediatr 131: 200–209. [CrossRef] [PubMed] [Google Scholar]
  • Jones PJ, Lin L, Gillingham LG, Yang H, Omar JM. 2014. Modulation of plasma N-acylethanolamine levels and physiological parameters by dietary fatty acid composition in humans. J Lipid Res 55: 2655–2664. [CrossRef] [PubMed] [Google Scholar]
  • Kabir M, Skurnik G, Naour N, et al. 2007. Treatment for 2 mo with n-3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 86: 1670–1679. [CrossRef] [PubMed] [Google Scholar]
  • Katona I, Freund TF. 2012. Multiple functions of endocannabinoid signaling in the brain. Annu Rev Neurosci 35: 529–558. [CrossRef] [PubMed] [Google Scholar]
  • Khera AV, Chaffin M, Wade KH, et al. 2019. polygenic prediction of weight and obesity trajectories from birth to adulthood. Cell 177(3): 587–596.e9. [PubMed] [Google Scholar]
  • Laye S., et al. 2015. N-3 polyunsaturated fatty acid and neuroinflammation in aging and Alzheimer’s disease. Nutr Aging 3: 33–47. [CrossRef] [Google Scholar]
  • Li J, Li FR, Wei D, et al. 2014. Endogenous-3 polyunsaturated fatty acid production confers resistance to obesity, dyslipidemia, and diabetes in mice. Mol Endocrinol 28(8): 1316–1328. [CrossRef] [PubMed] [Google Scholar]
  • Locke AE, et al. 2015. Genetic studies of body mass index yield new insights for obesity biology. Nature 518(7538): 197–206. [Google Scholar]
  • Loos RJF, Janssens ACJW. 2017. Predicting polygenic obesity using genetic information. Cell Metab 25(3): 535–543. [CrossRef] [PubMed] [Google Scholar]
  • Marquardt A, Stohr H, White K, Weber BH. 2000. Cdna cloning, genomic structure, and chromosomal localization of three, members of the human fatty acid desaturase family. Genomics 66: 175–183. [CrossRef] [PubMed] [Google Scholar]
  • Matias I, Carta G, Murru E, Petrosino S, Banni S, Di Marzo V. 2008. Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes. Biochim Biophys Acta 1781: 52–60. [CrossRef] [PubMed] [Google Scholar]
  • Micallef M, Munro I, Phang M, Garg M. 2009. Plasma n-3 polyunsaturated fatty acids are negatively associated with obesity. Br J Nutr 1–5. [PubMed] [Google Scholar]
  • Mori TA, Bao DQ, Burke V, Puddey IB, Watts GF, Beilin LJ. 1999. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 70: 817–825. [CrossRef] [PubMed] [Google Scholar]
  • Naughton SS, Mathai ML, Hryciw DH, McAinch AJ. 2013. Fatty acid modulation of the endocannabinoid system and the effect on food intake and metabolism. Int J Endocrinol 2013: 361895. [CrossRef] [PubMed] [Google Scholar]
  • Oh DY, Talukdar S, Bae EJ, et al. 2010. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142(5): 687–698. [CrossRef] [PubMed] [Google Scholar]
  • Patel KD, Davison JS, Pittman QJ, Sharkey KA. 2010. Cannabinoid CB(2) receptors in health and disease. Curr Med Chem 17: 1393–1410. [CrossRef] [PubMed] [Google Scholar]
  • Rossmeisl M, Jilkova ZM, Kuda O, et al. 2012. Metabolic effects of N-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids. Plos One 7(6, article e38834). [Google Scholar]
  • Savva SC, Chadjigeorgiou C, Hatzis C, et al. 2004. Association of adipose tissue arachidonic acid content with BMI and overweight status in children from Cyprus and Crete. Br J Nutr 91: 643–649. [CrossRef] [PubMed] [Google Scholar]
  • Schaeffer L, Gohlke H, Muller M, et al. 2006. Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 15: 1745–1756. [CrossRef] [PubMed] [Google Scholar]
  • Serhan CN, Chiang N, Van Dyke TE. 2008. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349–361. [Google Scholar]
  • Simopoulos AP. 1991. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 54: 438–463. [CrossRef] [PubMed] [Google Scholar]
  • Simopoulos AP, ed. The return of w3 fatty acids into the food supply. I. Land-based animal food products and their health effects, World Review of Nutrition and Dietetics 83 Karger Basel 1998. [Google Scholar]
  • Simopoulos AP. 2008. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 233:674–688. [CrossRef] [PubMed] [Google Scholar]
  • Simopoulos AP. Omega-6/omega-3 essential fatty acids: biological effects. In Simopoulos AP, Bazan NG, eds. Omega-3 fatty acids, the brain and retina. World Review of Nutrition and Dietetics vol. 99. Basel: Karger, 2009, pp. 1–16. [Google Scholar]
  • Simopoulos AP. 2010. Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk. Exp Biol Med (Maywood) 235(7): 785–795. [CrossRef] [PubMed] [Google Scholar]
  • Simopoulos AP, Robinson J. 1999. The omega diet. The lifesaving nutritional program based on the diet of the Island of Crete. New York: HarperCollins. [Google Scholar]
  • Simopoulos AP, Norman HA, Gillaspy JE, Duke JA. 1992. Common purslane: a source of omega-3 fatty acids and antioxidants. J Am Coll Nutr 11:374–382. [PubMed] [Google Scholar]
  • Stark KD, Van Elswyk ME, Higgins MR, Weatherford CA, Salem N Jr. 2016. Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Prog Lipid Res 63: 132–152. [CrossRef] [PubMed] [Google Scholar]
  • Thorsdottir I, Tomasson H, Gunnarsdottir I, et al. 2007. Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. Int J Obes 31(10): 1560–1566. [CrossRef] [PubMed] [Google Scholar]
  • Van Gaal L, Pi-Sunyer X, Despres JP, McCarthy C, Scheen A. 2008. Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in obesity (RIO) program. Diabetes Care 31: S229–S240. [CrossRef] [PubMed] [Google Scholar]
  • Viguerie N, Poitou C, Cancello R, Stich V, Clement K, Langin D. 2005. Transcriptomics applied to obesity and caloric restriction. Biochimie 87: 117–123. [CrossRef] [PubMed] [Google Scholar]
  • Wang L, Manson JE, Rautiainen S, et al. 2016. A prospective study of erythrocyte polyunsaturated fatty acid, weight gain, and risk of becoming overweight or obese in middle-aged and older women. Eur J Nutr 55(2): 687–697. [CrossRef] [PubMed] [Google Scholar]
  • Watanabe S, Doshi M, Hamazaki T. 2003. n-3 polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostaglandins Leukot Essent Fatty Acids 69: 51–59. [PubMed] [Google Scholar]
  • Wood JT, Williams JS, Pandarinathan L, Janero DR, Lammi-Keefe CJ, Makriyannis A. 2010. Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma. J Lipid Res 51: 1416–1423. [CrossRef] [PubMed] [Google Scholar]
  • Yoshida R, Ohkuri T, Jyotaki M, et al. 2010. Endocannabinoids selectively enhance sweet taste. Proc Natl Acad Sci USA 107: 935–939. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.